Prokidney (PROK) Non-Current Assets (2021 - 2026)
Prokidney's (PROK) quarterly Non-Current Assets came in at $57.9 million in Q1 2026, up 24.75% year-on-year from $46.4 million in Q1 2025, and up 5.44% on a QoQ basis from $54.9 million in Q4 2025.
Prokidney (PROK) Non-Current Assets (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Non-Current Assets data on file, last reported at $57.9 million in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 24.75% year-over-year to $57.9 million in Q1 2026; TTM through Mar 2026 was $212.1 million, a 14.61% increase from a year earlier, with the FY2025 full-year figure at $54.9 million, up 21.48% from the prior year.
- Non-Current Assets for Q1 2026 stood at $57.9 million, up from $54.9 million in the prior quarter.
- Over the last five years, Non-Current Assets for PROK reached as high as $250.4 million in Q2 2022 and fell as low as $13.1 million in Q3 2022.
- Historically, Non-Current Assets has averaged $64.5 million across 5 years, with a median of $46.4 million in 2023.
- On a YoY basis, Non-Current Assets climbed as much as 65845.09% in 2022 and fell as far as 94.77% in 2022.
- Year by year, Non-Current Assets stood at $13.3 million in 2022, then jumped by 249.52% to $46.4 million in 2023, then decreased by 2.62% to $45.2 million in 2024, then gained by 21.48% to $54.9 million in 2025, then gained by 5.44% to $57.9 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $57.9 million in Q1 2026, $54.9 million in Q4 2025, and $51.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 285.82 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 57.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.88 Mn |
| Dec 31, 2025 | 54.90 Mn |
| Sep 30, 2025 | 51.62 Mn |
| Jun 30, 2025 | 47.69 Mn |
| Mar 31, 2025 | 46.40 Mn |
| Dec 31, 2024 | 45.19 Mn |
| Sep 30, 2024 | 44.57 Mn |
| Jun 30, 2024 | 48.90 Mn |
| Mar 31, 2024 | 47.61 Mn |
| Dec 31, 2023 | 46.41 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 17.79 Mn |
| Mar 31, 2023 | 15.01 Mn |
| Dec 31, 2022 | 13.28 Mn |
| Sep 30, 2022 | 13.07 Mn |
| Jun 30, 2022 | 250.37 Mn |
| Mar 31, 2022 | 250.16 Mn |
| Dec 31, 2021 | 13.03 Mn |
| Sep 30, 2021 | 250.00 Mn |
| Jun 30, 2021 | 379,666.00 |